Anti-Human CD371/CLEC12A (BFENN1930U) is a research-grade recombinant antibody targeting CD371. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.